JSPRW

Jasper Therapeutics, Inc. JSPRW

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode JSPRW CELUW DBVT NRXPW SABSW
6M 6.90 % -21.25 % 112.93 % 41.13 % 27.76 %
YTD -46.50 % 57.50 % 381.54 % -53.95 % -45.81 %
1Y -35.93 % 112.84 % 270.85 % 59.67 % -13.85 %
3Y 156.43 % -90.38 % -4.57 % -64.99 % -55.50 %
5Y -89.20 % -98.26 % -6.29 % -75.00 % -97.76 %
10Y -86.15 % -94.75 % -90.94 % -75.14 % -97.76 %
From the beginning -86.15 % -94.75 % -86.33 % -75.14 % -97.76 %

Dividend